Stocks
Merck & Company Beats Q1 2026 Earnings Expectations in EPS and Revenue
Merck & Company (IT:1MRKX) has released its Q1 2026 earnings report, beating market expectations in both EPS and revenue. The company's actual EPS came in at €1.11, surpassing the consensus estimate of €1.28 by €0.17. Revenue for the quarter reached €14.07 billion, exceeding the expected figure of €13.77 billion by €307.25 million.
The Q1 2026 earnings report shows a modest revenue growth of +3.72% compared to the same period last year. The company's next earnings date is estimated for August 4, 2026, based on past reporting schedules.